Changing Lives Through Research

On the Job
Dr. Goldberg Spends
Research Year Targeting
Breast Cancer
Four years into her Jefferson residency,
Allison Goldberg, MD, is spending a
productive year in the lab of Kimmel
Cancer Center researcher Michael Lisanti,
MD, PhD. Over the past decade, Dr. Lisanti,
the Margaret Q. Landenberger Professor
in Breast Cancer Research and Chair
of Stem Cell Biology and Regenerative
Medicine at Jefferson, has been the 13th
most-cited biochemist and biologist in
the scientific literature.

Dr. Alec Beekley, assisted by Dr. Jim Sebesta, performing a femoral artery repair at the
31st Combat Support Hospital, Ibn Sina Hospital, in the International (formerly Green) Zone
of Baghdad, Iraq.

Beekley’s Combat Experience
Informs Research and Protocols
at Home and Abroad
Associate Professor Alec Beekley, MD,
joined the Division of Acute Care Surgery
in July 2010. As both a trauma surgeon
and a bariatric surgeon, he will now apply
the experience he gained during multiple
tours of duty in Iraq and Afghanistan,
where he served as Lieutenant Colonel
in the U.S. Army Medical Corps and was
awarded a Bronze Star.

The challenge was to
collect meaningful clinical
data for every case, given
how quickly soldiers were
being treated
Dr. Beekley completed his residency at
Madigan Army Medical Center in Ft.
Lewis, Washington. From November
2002 through March 2003, he served
as staff surgeon for the 102nd Forward
Surgical Team stationed in Afghanistan.
In April 2004 he deployed with the 912th
Forward Surgical Team to Al Mussayib,

Iraq, and then volunteered to stay
another six months at the 31st Combat
Support Hospital (CSH) in Baghdad when
the insurgency was growing. During
Operation Phantom Fury (November and
December 2004) he experienced one of
the war’s highest monthly caseloads: some
one thousand casualties, which he and his
team treated around the clock.
It was during this first deployment to
Iraq that Dr. Beekley witnessed that a
significant number of the casualties were
arriving to the hospital trauma bay not
having been treated with tourniquets. He
believed that, in some cases, tourniquets
would have saved lives. This experience
made Dr. Beekley an expert on tourniquet
use in injury to the extremities, and he
created one of the war’s first datasets on
tourniquet use which has since been cited
in dozens of publications reexamining
the protocol for tourniquet use in
combat triage.
Dr. Beekley also helped develop a trauma
database and registry for the joint
theater. “There were many ‘grass-roots’
researchers collecting data as casualties

Most of Dr. Lisanti’s research redefines
the long-held Warburg Effect hypothesis,
which postulated that a change in cellular
metabolism—that is, an increased level of
glycolysis (the conversion of glucose into
energy)—causes cancer. Since 2009 Dr.
Lisanti has researched what he calls the
Reverse Warburg Effect, proposing that
glycolysis occurs in stromal fibroblasts
(connective tissue cells) near the tumor
and not in the tumor cells themselves. This
significantly impacts our understanding of
how tumors develop.
Dr. Goldberg is working with animal
models to alter the glucose-making
pathways of the fibroblasts, to evaluate
if those alterations affect the size and
weight of tumors from triple negative forms
of breast cancer. Triple negative breast
cancers are so named because they lack
the three crucial receptors to which today’s

were coming in,” Dr. Beekley explains.
“In most cases, these researchers were
interested in a specific topic, such as
vascular injuries. The challenge was to
collect meaningful clinical data for every
case, given how quickly soldiers were
being treated.”
Based upon Dr. Beekley’s findings,
Colonel John Holcomb, who headed the
Army’s Institute for Surgical Research,
recommended to the Surgeon General
that the Army provide some 400,000
modular tourniquets that soldiers could
carry in an individual first aid kit (IFAK).
During the troop surge in 2007, Dr.
Beekley was again deployed to Iraq
as Director of the Deployed Combat
Casualty Research Team. There he
continued to direct research in multiple
areas of combat casualty care including
the use of fresh whole blood (rather
than stored platelets and plasma) in
resuscitation. He recalls distinctly the

most successful molecularly targeted drugs
attach. She is also genetically manipulating
fibroblasts, to turn on and off autophagy
(cell self-digestion). “We are hoping this
research will lead to new targeted drug
therapies,” says Dr. Goldberg.
Dr. Lisanti notes that having a surgical
resident in his lab is a great asset. “Dr.
Goldberg is a gifted surgeon who helps
us see our work in new, more clinically
relevant ways,” he says.
Dr. Goldberg reflects, “In the OR, every
step is scripted and rehearsed. There is
no margin for error. In the lab, I’m free to
pursue an idea and just see what happens.
It’s been refreshing and rewarding,” she
says. Dr. Goldberg is expecting twins
in June and will return to her clinical
responsibilities later this summer.

dramatic effect of fresh whole blood on
a soldier in critical condition, who was
quickly stabilized when he was transfused
with 22 units donated by his fellow
soldiers. This and similar observations
by others at the 31st CSH prompted
a reexamination of the entire blood
transfusion protocol, which historically
called for fresh whole blood infusions
only once supplies of stored platelets and
plasma had been exhausted.
Dr. Beekley is honored to have played a
role in these areas of surgical research.
“I think of medical research as a process,”
he says. “Everyone can’t publish the
breakthrough findings, but every
little piece contributes to the overall
advancement of knowledge.”
The Department of Surgery is grateful
to benefit from Dr. Beekley’s unique and
valuable experience gained during his
service to our nation.
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